Erythromycin Ethylsuccinate 75834-0295-01
- Manufacturer
- Nivagen Pharmaceuticals, Inc.
- Dosage Form
- Suspension
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 1, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA216212
Need to source Erythromycin Ethylsuccinate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Erythromycin Ethylsuccinate | 200 mg/5mL |
Drug Class
Decreased Sebaceous Gland Activity [PE]Macrolide Antimicrobial [EPC]Macrolide [EPC]
Selected Package
75834-0295-01Selected100 mL in 1 BOTTLE (75834-295-01)